| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of Pharmacokinetic Interaction Between Intravenous Peramivir and Oral Oseltamivir or Rimantadine in Humans
|
Atiee, George
|
|
2012
|
|
9 |
p. 1410-1419
|
artikel
|
| 2 |
Abstracts
|
|
|
2010
|
|
9 |
p. 1058-1095
|
artikel
|
| 3 |
Abstracts
|
|
|
2002
|
|
9 |
p. 1051-1071
|
artikel
|
| 4 |
Abstracts
|
|
|
2001
|
|
9 |
p. 1014-1033
|
artikel
|
| 5 |
Abstracts
|
|
|
2006
|
|
9 |
p. 1061-1095
|
artikel
|
| 6 |
Abstracts: 40th Annual Meeting of the American College of Clinical Pharmacology, September 11-13, 2011, Chicago, Illinois
|
|
|
2011
|
|
9 |
p. 1326-1369
|
artikel
|
| 7 |
Abstracts Thirty-Fourth Annual Meeting American College of Clinical Pharmacology September 11-13, 2005 Rockville, Maryland
|
|
|
2005
|
|
9 |
p. 1067-1096
|
artikel
|
| 8 |
Abstracts Thirty-Second Annual Meeting American College of Clinical Pharmacology September 21-23, 2003 Wesley Chapel, Florida
|
|
|
2003
|
|
9 |
p. 1016-1040
|
artikel
|
| 9 |
A Comment on “Adverse Drug Reactions and Avalanches: Life at the Edge of Chaos”
|
Dokoumetzidis, Aristides
|
|
2006
|
|
9 |
p. 1057-1060
|
artikel
|
| 10 |
ACoP: The Tools, Carpenters, and Architects Building the Discipline of Pharmacometrics
|
Brundage, Richard C.
|
|
2010
|
|
9 |
p. 7S-8S
|
artikel
|
| 11 |
Acute and Chronic Effects of Vinpocetine on Cerebral Hemodynamics and Neuropsychological Performance in Multi-infarct Patients
|
Kemény, Vendel
|
|
2005
|
|
9 |
p. 1048-1054
|
artikel
|
| 12 |
Advances in Pharmacogenetics and Pharmacogenomics
|
Vesell, Elliot S.
|
|
2000
|
|
9 |
p. 930-938
|
artikel
|
| 13 |
American College of Clinical Pharmacology
|
|
|
2004
|
|
9 |
p. 1075-1076
|
artikel
|
| 14 |
American College of Clinical Pharmacology
|
|
|
2005
|
|
9 |
p. 1097-1098
|
artikel
|
| 15 |
An Evolution of Drug Development and Clinical Pharmacology during the 20th Century
|
Heath, Gene
|
|
2000
|
|
9 |
p. 918-929
|
artikel
|
| 16 |
An Overview of Antihypertensive Therapy in the 20th Century
|
Piepho, Robert W.
|
|
2000
|
|
9 |
p. 967-977
|
artikel
|
| 17 |
An Overview of the Pharmacokinetics of Cilomilast (Ariflo®), a New, Orally Active Phosphodiesterase 4 Inhibitor, in Healthy Young and Elderly Volunteers
|
Zussman, Barry D.
|
|
2001
|
|
9 |
p. 950-958
|
artikel
|
| 18 |
Antiviral Information Management System (AIMS): A Prototype for Operational Innovation in Drug Development
|
Jadhav, Pravin R.
|
|
2010
|
|
9 |
p. 50S-55S
|
artikel
|
| 19 |
A Pharmacokinetic Study of the Combined Administration of Amiodarone and Ximelagatran, an Oral Direct Thrombin Inhibitor
|
Teng, Renli
|
|
2004
|
|
9 |
p. 1063-1071
|
artikel
|
| 20 |
A Preliminary Assessment of the Critical Differences Between Novel Oral Anticoagulants Currently in Development
|
McBride, Brian F.
|
|
2005
|
|
9 |
p. 1004-1017
|
artikel
|
| 21 |
A Proof-of-Concept and Drug-Drug Interaction Study of Pamapimod, a Novel p38 MAP Kinase Inhibitor, With Methotrexate in Patients With Rheumatoid Arthritis
|
Xiaoping Zhang,
|
|
2010
|
|
9 |
p. 1031-1038
|
artikel
|
| 22 |
A Review and Assessment of Potential Sources of Ethnic Differences in Drug Responsiveness
|
Bjornsson, Thorir D.
|
|
2003
|
|
9 |
p. 943-967
|
artikel
|
| 23 |
A Review of the Pharmacologic and Pharmacokinetic Aspects of Rosuvastatin
|
White, C. Michael
|
|
2002
|
|
9 |
p. 963-970
|
artikel
|
| 24 |
Aripiprazole Associated With Acute Dystonia, Akathisia, and Parkinsonism in a Single Patient
|
Saddichha, Sahoo
|
|
2012
|
|
9 |
p. 1448-1449
|
artikel
|
| 25 |
Armodafinil and Modafinil in Patients With Excessive Sleepiness Associated With Shift Work Disorder: A Pharmacokinetic/Pharmacodynamic Model for Predicting and Comparing Their Concentration-Effect Relationships
|
Darwish, Mona
|
|
2012
|
|
9 |
p. 1328-1342
|
artikel
|
| 26 |
A Study of the Pharmacokinetic Interaction of Istradefylline, a Novel Therapeutic for Parkinson's Disease, and Atorvastatin
|
Rao, N.
|
|
2008
|
|
9 |
p. 1092-1098
|
artikel
|
| 27 |
A Supratherapeutic Dose of the Janus Kinase Inhibitor Tasocitinib (CP-690,550) Does Not Prolong QTc Interval in Healthy Participants
|
Krishnaswami, Sriram
|
|
2011
|
|
9 |
p. 1256-1263
|
artikel
|
| 28 |
Bioavailability of Amlodipine Besylate/Atorvastatin Calcium Combination Tablet
|
Chung, Menger
|
|
2006
|
|
9 |
p. 1030-1037
|
artikel
|
| 29 |
Bridging Pharmacology and Pathophysiology via Systems Modeling
|
D'Argenio, David Z.
|
|
2010
|
|
9 |
p. 56S-57S
|
artikel
|
| 30 |
Bupivacaine Extended Release Liposome Injection Does Not Prolong QTc Interval in a Thorough QT/QTc Study in Healthy Volunteers
|
Naseem, Asif
|
|
2012
|
|
9 |
p. 1441-1447
|
artikel
|
| 31 |
Celecoxib Does Not Affect the Antiplatelet Activity of Aspirin in Healthy Volunteers
|
Wilner, Keith D.
|
|
2002
|
|
9 |
p. 1027-1030
|
artikel
|
| 32 |
Clinical Pharmacology Abstracts to be Presented at the Twenty-Seventh Annual Meeting of the American College of Clinical Pharmacology
|
|
|
1998
|
|
9 |
p. 842-886
|
artikel
|
| 33 |
Concomitant Tacrolimus and Micafungin Pharmacokinetics in Healthy Volunteers
|
Hebert, Mary F.
|
|
2005
|
|
9 |
p. 1018-1024
|
artikel
|
| 34 |
Coriolus versicolor: A Medicinal Mushroom with Promising Immunotherapeutic Values
|
Chu, Kevin K. W.
|
|
2002
|
|
9 |
p. 976-984
|
artikel
|
| 35 |
Corrigendum
|
|
|
2012
|
|
9 |
p. NP4-NP5
|
artikel
|
| 36 |
Dabigatran Etexilate in Atrial Fibrillation Patients With Severe Renal Impairment: Dose Identification Using Pharmacokinetic Modeling and Simulation
|
Lehr, Thorsten
|
|
2012
|
|
9 |
p. 1373-1378
|
artikel
|
| 37 |
Defining the Future of Pharmacometrics: The American Society of Pharmacometrics
|
Pfister, Marc
|
|
2010
|
|
9 |
p. 158S-158S
|
artikel
|
| 38 |
Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Pitavastatin on Steady-State Warfarin in Healthy Adult Volunteers
|
Inagaki, Yoichiro
|
|
2011
|
|
9 |
p. 1302-1309
|
artikel
|
| 39 |
Effect of a Single Gemfibrozil Dose on the Pharmacokinetics of Rosuvastatin in Bile and Plasma in Healthy Volunteers
|
Bergman, Ebba
|
|
2010
|
|
9 |
p. 1039-1049
|
artikel
|
| 40 |
Effect of Carisbamate on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Participants
|
Gonzalez, Martha
|
|
2012
|
|
9 |
p. 1420-1429
|
artikel
|
| 41 |
Effect of Exenatide on the Steady-State Pharmacokinetics of Digoxin
|
Kothare, Prajakti A.
|
|
2005
|
|
9 |
p. 1032-1037
|
artikel
|
| 42 |
Effect of Meal Timing Not Critical for the Pharmacokinetics of Tegaserod (HTF 919)
|
Zhou, Honghui
|
|
1999
|
|
9 |
p. 911-919
|
artikel
|
| 43 |
Effect of Multiple Doses of Montelukast, a CysLT1 Receptor Antagonist, on Digoxin Pharmacokinetics in Healthy Volunteers
|
Depré, Marleen
|
|
1999
|
|
9 |
p. 941-944
|
artikel
|
| 44 |
Effects of Celecoxib and Diclofenac on Blood Pressure, Renal Function, and Vasoactive Prostanoids in Young and Elderly Subjects
|
Dilger, Karin
|
|
2002
|
|
9 |
p. 985-994
|
artikel
|
| 45 |
Effects of the Peroxisome Proliferator Activated Receptor-γ Coactivator-1α (PGC-1α) Thr394Thr and Gly482Ser Polymorphisms on Rosiglitazone Response in Chinese Patients With Type 2 Diabetes Mellitus
|
Zhang, Ke-Han
|
|
2010
|
|
9 |
p. 1022-1030
|
artikel
|
| 46 |
Efficacy and Pharmacokinetics of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B and Renal Impairment
|
Shiffman, Mitchell L.
|
|
2011
|
|
9 |
p. 1293-1301
|
artikel
|
| 47 |
Enhanced Sensitivity to Drug-Induced QT Interval Lengthening in Patients With Heart Failure Due to Left Ventricular Systolic Dysfunction
|
Tisdale, James E.
|
|
2012
|
|
9 |
p. 1296-1305
|
artikel
|
| 48 |
Erratum
|
|
|
2003
|
|
9 |
p. 1015-1015
|
artikel
|
| 49 |
Erratum
|
|
|
2004
|
|
9 |
p. 1072-1074
|
artikel
|
| 50 |
Evaluating Possible Pharmacokinetic Interactions between Tobramycin, Piperacillin, and a Combination of Piperacillin and Tazobactam in Patients with Various Degrees of Renal Impairment
|
Dowell, James A.
|
|
2001
|
|
9 |
p. 979-986
|
artikel
|
| 51 |
Evaluation and Recommendations on Adaptive Dose-Ranging Trials: Highlights From the PhRMA Adaptive Dose-Ranging Studies Working Group
|
Pinheiro, José
|
|
2010
|
|
9 |
p. 47S-49S
|
artikel
|
| 52 |
Evaluation of a [13C]-Dextromethorphan Breath Test to Assess CYP2D6 Phenotype
|
Leeder, J. Steven
|
|
2008
|
|
9 |
p. 1041-1051
|
artikel
|
| 53 |
Evaluation of Highly Bound Drugs: Interspecies, Intersubject, and Related Comparisons
|
Collins, Jerry M.
|
|
2002
|
|
9 |
p. 971-975
|
artikel
|
| 54 |
Evaluation of In Vitro Drug Interactions with Karenitecin, a Novel, Highly Lipophilic Camptothecin Derivative in Phase II Clinical Development
|
Smith, Judith A.
|
|
2003
|
|
9 |
p. 1008-1014
|
artikel
|
| 55 |
Evaluation of the Administration Time Effect on the Cumulative Cortisol Suppression and Cumulative Lymphocytes Suppression for Once-Daily Inhaled Corticosteroids: A Population Modeling/Simulation Approach
|
Kai Wu,
|
|
2008
|
|
9 |
p. 1069-1080
|
artikel
|
| 56 |
Evolution of Drugs That Preserve Renal Function
|
Basta, Emad
|
|
2000
|
|
9 |
p. 978-989
|
artikel
|
| 57 |
Evolution of Pharmacokinetics and Pharmacokinetic/Dynamic Correlations during the 20th Century
|
Hochhaus, Guenther
|
|
2000
|
|
9 |
p. 908-917
|
artikel
|
| 58 |
Exposure-Response Modeling of Darbepoetin Alfa in Anemic Patients With Chronic Kidney Disease Not Receiving Dialysis
|
Doshi, Sameer
|
|
2010
|
|
9 |
p. 75S-90S
|
artikel
|
| 59 |
Extending Worldwide Clinical Pharmacology Education Through a Pricing Approach
|
Ameer, Barbara
|
|
2005
|
|
9 |
p. 982-986
|
artikel
|
| 60 |
FDA Evaluations Using In Vitro Metabolism to Predict and Interpret In Vivo Metabolic Drug-Drug Interactions: Impact on Labeling
|
Davit, Barbara
|
|
1999
|
|
9 |
p. 899-910
|
artikel
|
| 61 |
Fixed Dosing Versus Body Size—Based Dosing of Monoclonal Antibodies in Adult Clinical Trials
|
Wang, Diane D.
|
|
2009
|
|
9 |
p. 1012-1024
|
artikel
|
| 62 |
Food Does Not Affect the Pharmacokinetics of Tesaglitazar, a Novel Dual Peroxisome Proliferator-Activated Receptor β/γ Agonist
|
Samuelsson, S.
|
|
2006
|
|
9 |
p. 1017-1022
|
artikel
|
| 63 |
Food Increased the Bioavailability of BMS-690514, an Orally Active EGFR/HER2/VEGF Receptor Kinase Inhibitor, in Healthy Subjects
|
Vakkalagadda, Blisse
|
|
2012
|
|
9 |
p. 1350-1356
|
artikel
|
| 64 |
Fostamatinib, a Syk-Kinase Inhibitor, Does Not Affect Methotrexate Pharmacokinetics in Patients With Rheumatoid Arthritis
|
Baluom, Muhammad
|
|
2011
|
|
9 |
p. 1310-1318
|
artikel
|
| 65 |
Fostering Culture and Optimizing Organizational Structure for Implementing Model-Based Drug Development
|
Liping Zhang,
|
|
2010
|
|
9 |
p. 146S-150S
|
artikel
|
| 66 |
Gabapentin Does Not Affect Antipyrine Clearance
|
Allen, Elizabeth
|
|
1999
|
|
9 |
p. 934-935
|
artikel
|
| 67 |
Galantamine Pharmacokinetics, Safety, and Tolerability Profiles Are Similar in Healthy Caucasian and Japanese Subjects
|
Zhao, Qinying
|
|
2002
|
|
9 |
p. 1002-1010
|
artikel
|
| 68 |
Gastric Function in the Elderly: Effects on Absorption of Ketoconazole
|
Hurwitz, Aryeh
|
|
2003
|
|
9 |
p. 996-1002
|
artikel
|
| 69 |
Glutathione S-Transferase A1 Genetic Variants Reduce Busulfan Clearance in Children Undergoing Hematopoietic Cell Transplantation
|
Johnson, L'Aurelle
|
|
2008
|
|
9 |
p. 1052-1062
|
artikel
|
| 70 |
Hemodynamic Effects of Acute Administration of Atomoxetine and Methylphenidate
|
Kelly, Ronan P.
|
|
2005
|
|
9 |
p. 851-855
|
artikel
|
| 71 |
Highlights and Book Reviews
|
Bonate, Peter
|
|
2006
|
|
9 |
p. 1052-1056
|
artikel
|
| 72 |
Human Pharmacokinetics/Pharmacodynamics of an Interleukin-4 and Interleukin-13 Dual Antagonist in Asthma
|
Burmeister Getz, Elise
|
|
2009
|
|
9 |
p. 1025-1036
|
artikel
|
| 73 |
Ibandronate: A Clinical Pharmacological and Pharmacokinetic Update
|
Barrett, Joanne
|
|
2004
|
|
9 |
p. 951-965
|
artikel
|
| 74 |
Ibuprofen Extrudate, a Novel, Rapidly Dissolving Ibuprofen Formulation: Relative Bioavailability Compared to Ibuprofen Lysinate and Regular Ibuprofen, and Food Effect on All Formulations
|
Klueglich, Matthias
|
|
2005
|
|
9 |
p. 1055-1061
|
artikel
|
| 75 |
Impact of Disease States on the Pharmacokinetics and Pharmacodynamics of Angiotensin-Converting Enzyme Inhibitors
|
LeBlanc, Jaclyn M.
|
|
2006
|
|
9 |
p. 968-980
|
artikel
|
| 76 |
Impact of Sildenafil on Survival of Patients With Idiopathic Pulmonary Arterial Hypertension
|
Zeng, Wei-Jie
|
|
2012
|
|
9 |
p. 1357-1364
|
artikel
|
| 77 |
Impersistence of Depression in Youth: Implications for Drug Study Design
|
Malone, Richard P.
|
|
2006
|
|
9 |
p. 1044-1051
|
artikel
|
| 78 |
Increased Risk of Myocardial Infarction Associated With Angiotensin-Converting Enzyme Gene Polymorphism Is Age Dependent
|
Hamelin, Bettina A.
|
|
2011
|
|
9 |
p. 1286-1292
|
artikel
|
| 79 |
Influence of Simulated Weightlessness on the Intramuscular and Oral Pharmacokinetics of Promethazine in 12 Human Volunteers
|
Gandia, Peggy
|
|
2006
|
|
9 |
p. 1008-1016
|
artikel
|
| 80 |
Inhibition of Caffeine Metabolism by Estrogen Replacement Therapy in Postmenopausal Women
|
Pollock, Bruce G.
|
|
1999
|
|
9 |
p. 936-940
|
artikel
|
| 81 |
Interactions of Prednisolone and other Immunosuppressants Used in Dual Treatment of Systemic Lupus Erythematosus in Lymphocyte Proliferation Assays
|
Kamal, Mohamed A.
|
|
2004
|
|
9 |
p. 1034-1045
|
artikel
|
| 82 |
Interactive Visualization and Communication for Increased Impact of Pharmacometrics
|
Krause, Andreas
|
|
2010
|
|
9 |
p. 140S-145S
|
artikel
|
| 83 |
Interindividual Variability in Pharmacokinetics of Generic Nucleoside Reverse Transcriptase Inhibitors in TB/HIV-Coinfected Ghanaian Patients: UGT2B7*1c Is Associated With Faster Zidovudine Clearance and Glucuronidation
|
Kwara, Awewura
|
|
2009
|
|
9 |
p. 1079-1090
|
artikel
|
| 84 |
Investigation of a Possible Interaction Between Quetiapine and Armodafinil in Patients With Schizophrenia: An Open-Label, Multiple-Dose Study
|
Darwish, Mona
|
|
2012
|
|
9 |
p. 1399-1409
|
artikel
|
| 85 |
Is There an Association Between 5-Azacitidine and Ototoxicity?
|
Malik, Afshan
|
|
2010
|
|
9 |
p. 1056-1057
|
artikel
|
| 86 |
Lack of Bioequivalence of Levofloxacin when Coadministered with a Mineral-Fortified Breakfast of Juice and Cereal
|
Amsden, Guy W.
|
|
2003
|
|
9 |
p. 990-995
|
artikel
|
| 87 |
Lack of Pharmacokinetic Interaction between Oral Pantoprazole and Cisapride in Healthy Adults
|
Ferron, Geraldine M.
|
|
1999
|
|
9 |
p. 945-950
|
artikel
|
| 88 |
Lack of Pharmacokinetic Interactions between Cilomilast and Theophylline or Smoking in Healthy Volunteers
|
Murdoch, Robert D.
|
|
2004
|
|
9 |
p. 1046-1053
|
artikel
|
| 89 |
Lack of Pharmacokinetic Interactions Between Transdermal Rotigotine and Oral Levodopa/Carbidopa
|
Braun, Marina
|
|
2009
|
|
9 |
p. 1047-1055
|
artikel
|
| 90 |
Lack of Weight-Based Dose Dependency and Intraindividual Variability of Omeprazole for CYP2C19 Phenotyping
|
Kim, Myong-Jin
|
|
2004
|
|
9 |
p. 966-973
|
artikel
|
| 91 |
Lessons Learned from the Past: A Guide for the Future of Clinical Pharmacology in the 21st Century
|
Lathers, Claire M.
|
|
2000
|
|
9 |
p. 946-966
|
artikel
|
| 92 |
Linezolid Pharmacokinetics in Patients With Acute Renal Failure Undergoing Continuous Venovenous Hemodiafiltration
|
Carcelero, Esther
|
|
2012
|
|
9 |
p. 1430-1435
|
artikel
|
| 93 |
Lisdexamfetamine Dimesylate: Linear Dose-Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open-Label Single-Dose Pharmacokinetic Study in Healthy Adult Volunteers
|
Ermer, James
|
|
2010
|
|
9 |
p. 1001-1010
|
artikel
|
| 94 |
Long-Term Therapy With Thalidomide in Hereditary Hemorrhagic Telangiectasia: Case Report and Literature Review
|
Chen, Chih-Hsuan
|
|
2012
|
|
9 |
p. 1436-1440
|
artikel
|
| 95 |
Meclizine Metabolism and Pharmacokinetics: Formulation on Its Absorption
|
Wang, Zhijun
|
|
2012
|
|
9 |
p. 1343-1349
|
artikel
|
| 96 |
Microbial Biofilms: Their Development and Significance for Medical Device–Related Infections
|
Habash, Marc
|
|
1999
|
|
9 |
p. 887-898
|
artikel
|
| 97 |
Midazolam Disposition in Patients Undergoing Continuous Venovenous Hemodialysis
|
Bolon, M.
|
|
2001
|
|
9 |
p. 959-962
|
artikel
|
| 98 |
Missing Data in Model-Based Pharmacometric Applications: Points to Consider
|
Gastonguay, Marc R.
|
|
2010
|
|
9 |
p. 63S-74S
|
artikel
|
| 99 |
Model-Based Analysis of Covariate Effects on Population Pharmacokinetics of Thrombomodulin Alfa in Patients With Disseminated Intravascular Coagulation and Normal Subjects
|
Tsuruta, Kazuhisa
|
|
2011
|
|
9 |
p. 1276-1285
|
artikel
|
| 100 |
Model-Based Drug Development: Strengths, Weaknesses, Opportunities, and Threats for Broad Application of Pharmacometrics in Drug Development
|
Wetherington, Jeffrey D.
|
|
2010
|
|
9 |
p. 31S-46S
|
artikel
|
| 101 |
Model-Based Drug Development Survey Finds Pharmacometrics Impacting Decision Making in the Pharmaceutical Industry
|
Stone, Julie A.
|
|
2010
|
|
9 |
p. 20S-30S
|
artikel
|
| 102 |
Model-Based Evaluation of QTc Interval Risk: An Increasing Emphasis on Early Decision Making
|
Krishna, Rajesh
|
|
2009
|
|
9 |
p. 1010-1011
|
artikel
|
| 103 |
Models for Event-Driven Data: Longitudinal Daily Adverse Event and Dropout
|
Miller, Raymond
|
|
2010
|
|
9 |
p. 58S-62S
|
artikel
|
| 104 |
Novel Formulations of Cetrorelix Acetate in Healthy Men: Pharmacodynamic Effects and Noncompartmental Pharmacokinetics
|
Erb, Katharina
|
|
2002
|
|
9 |
p. 995-1001
|
artikel
|
| 105 |
Observation and Experiment on the Cusp of Collaboration: A Parallel Examination of Clinical Pharmacology and Pharmacoepidemiology
|
Lehmann, David F.
|
|
2000
|
|
9 |
p. 939-945
|
artikel
|
| 106 |
Pediatric Licensing Status and the Availability of Suitable Formulations for New Medical Entities Approved in the United States Between 1998 and 2002
|
Balakrishnan, Komathi
|
|
2006
|
|
9 |
p. 1038-1043
|
artikel
|
| 107 |
Percutaneous Absorption and Pharmacokinetics of Eflornithine HCl 13.9% Cream in Women with Unwanted Facial Hair
|
Malhotra, Bimal
|
|
2001
|
|
9 |
p. 972-978
|
artikel
|
| 108 |
Pharmacokinetic and Pharmacodynamic Differences between Ocular and Nasal Instillation of Carteolol on Intraocular Pressure and Heart Rate in Japanese Men with High CYP2D6 Activity
|
Ishii, Yoko
|
|
2002
|
|
9 |
p. 1020-1026
|
artikel
|
| 109 |
Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin after Single and Multiple Doses in Healthy Volunteers
|
Ramakrishnan, Rohini
|
|
2004
|
|
9 |
p. 991-1002
|
artikel
|
| 110 |
Pharmacokinetic Evaluation of the Possible Interaction between Selected Concomitant Medications and Orlistat at Steady State in Healthy Subjects
|
Zhi, Jianguo
|
|
2002
|
|
9 |
p. 1011-1019
|
artikel
|
| 111 |
Pharmacokinetic-Pharmacodynamic Assessment of the Interrelationships Between Tesaglitazar Exposure and Renal Function in Patients With Type 2 Diabetes Mellitus
|
Hamrén, Bengt
|
|
2012
|
|
9 |
p. 1317-1327
|
artikel
|
| 112 |
Pharmacokinetic-Pharmacodynamic Modeling of Dalbavancin, a Novel Glycopeptide Antibiotic
|
Dowell, James A.
|
|
2008
|
|
9 |
p. 1063-1068
|
artikel
|
| 113 |
Pharmacokinetics and Pharmacodynamic Response of Methylprednisolone in Premenopausal Renal Transplant Recipients
|
Tornatore, Kathleen M.
|
|
2004
|
|
9 |
p. 1003-1011
|
artikel
|
| 114 |
Pharmacokinetics and Pharmacodynamics of Argatroban in Combination with a Platelet Glycoprotein IIB/IIIA Receptor Antagonist in Patients Undergoing Percutaneous Coronary Intervention
|
Cox, Donna S.
|
|
2004
|
|
9 |
p. 981-990
|
artikel
|
| 115 |
Pharmacokinetics and Pharmacodynamics of MK-5046, a Bombesin Receptor Subtype-3 (BRS-3) Agonist, in Healthy Patients
|
Reitman, Marc L.
|
|
2012
|
|
9 |
p. 1306-1316
|
artikel
|
| 116 |
Pharmacokinetics and Pharmacodynamics of Pegfilgrastim in Subjects With Various Degrees of Renal Function
|
Yang, Bing-Bing
|
|
2008
|
|
9 |
p. 1025-1031
|
artikel
|
| 117 |
Pharmacokinetics and Safety of Solifenacin Succinate in Healthy Young Men
|
Smulders, Ronald A.
|
|
2004
|
|
9 |
p. 1023-1033
|
artikel
|
| 118 |
Pharmacokinetics, Excretion, and Mass Balance of 14C after Administration of 14C-Cholesterol-Labeled AmBisome to Healthy Volunteers
|
Bekersky, Ihor
|
|
2001
|
|
9 |
p. 963-971
|
artikel
|
| 119 |
Pharmacokinetics of Dapoxetine, a New Treatment for Premature Ejaculation: Impact of Age and Effects of a High-Fat Meal
|
Dresser, Mark J.
|
|
2006
|
|
9 |
p. 1023-1029
|
artikel
|
| 120 |
Pharmacokinetics of Efavirenz When Co-administered With Rifampin in TB/HIV Co-infected Patients: Pharmacogenetic Effect of CYP2B6 Variation
|
Kwara, Awewura
|
|
2008
|
|
9 |
p. 1032-1040
|
artikel
|
| 121 |
Pharmacokinetics of Hydroxyurea in Plasma and Cerebrospinal Fluid of HIV-1-Infected Patients
|
Gwilt, Peter R.
|
|
2003
|
|
9 |
p. 1003-1007
|
artikel
|
| 122 |
Pharmacokinetics of Oral Ibuprofen in Premature Infants
|
Sharma, Pramod Kumar
|
|
2003
|
|
9 |
p. 968-973
|
artikel
|
| 123 |
Pharmacokinetics, Pharmacodynamics, and Safety of Ticagrelor in Volunteers With Severe Renal Impairment
|
Butler, Kathleen
|
|
2012
|
|
9 |
p. 1388-1398
|
artikel
|
| 124 |
Pharmacokinetics, Safety, and Biologic Effects of Azithromycin in Extremely Preterm Infants at Risk for Ureaplasma Colonization and Bronchopulmonary Dysplasia
|
Hassan, Hazem E.
|
|
2011
|
|
9 |
p. 1264-1275
|
artikel
|
| 125 |
Pharmacometrics 2020
|
Gobburu, Jogarao V. S.
|
|
2010
|
|
9 |
p. 151S-157S
|
artikel
|
| 126 |
Pharmacometrics as a Discipline Is Entering the “Industrialization” Phase: Standards, Automation, Knowledge Sharing, and Training Are Critical for Future Success
|
Romero, Klaus
|
|
2010
|
|
9 |
p. 9S-19S
|
artikel
|
| 127 |
Population Modeling of Filgrastim PK-PD in Healthy Adults Following Intravenous and Subcutaneous Administrations
|
Krzyzanski, Wojciech
|
|
2010
|
|
9 |
p. 101S-112S
|
artikel
|
| 128 |
Population Pharmacokinetic Analysis of Linezolid in Patients With Infectious Disease: Application to Lower Body Weight and Elderly Patients
|
Abe, Sadahiro
|
|
2009
|
|
9 |
p. 1071-1078
|
artikel
|
| 129 |
Population Pharmacokinetic-Pharmacodynamic Modeling of Biological Agents: When Modeling Meets Reality
|
Mould, Diane R.
|
|
2010
|
|
9 |
p. 91S-100S
|
artikel
|
| 130 |
Population Pharmacokinetics of Golimumab, an Anti—Tumor Necrosis Factor-α Human Monoclonal Antibody, in Patients With Psoriatic Arthritis
|
Zhenhua Xu,
|
|
2009
|
|
9 |
p. 1056-1070
|
artikel
|
| 131 |
Possible Induction of Cholinesterase in Epileptic Patients Treated with Anticonvulsant Drugs: Relationship with Lipoprotein Levels
|
Tutor-Crespo, María J.
|
|
2004
|
|
9 |
p. 974-980
|
artikel
|
| 132 |
Practical Therapeutic Drug Management in HIV-Infected Patients: Use of Population Pharmacokinetic Models Supplemented by Individualized Bayesian Dose Optimization
|
Neely, Michael
|
|
2008
|
|
9 |
p. 1081-1091
|
artikel
|
| 133 |
QT and QTc Interval With Standard and Supratherapeutic Doses of Darifenacin, a Muscarinic M3 Selective Receptor Antagonist for the Treatment of Overactive Bladder
|
Serra, Denise B.
|
|
2005
|
|
9 |
p. 1038-1047
|
artikel
|
| 134 |
Quantitative Clinical Pharmacology: Making Paradigm Shifts a Reality
|
Krishna, Rajesh
|
|
2006
|
|
9 |
p. 966-967
|
artikel
|
| 135 |
Rabeprazole: Pharmacokinetics and Tolerability in Patients with Stable, End-Stage Renal Failure
|
Keane, William F.
|
|
1999
|
|
9 |
p. 927-933
|
artikel
|
| 136 |
Relationship of Arachidonic Acid Concentration to Cyclooxygenase-Dependent Human Platelet Aggregation
|
Burke, Joanne
|
|
2003
|
|
9 |
p. 983-989
|
artikel
|
| 137 |
Review: Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban
|
Morell, Jason
|
|
2010
|
|
9 |
p. 986-1000
|
artikel
|
| 138 |
Risperidone Long-Acting Injection: Pharmacokinetics Following Administration in Deltoid Versus Gluteal Muscle in Schizophrenic Patients
|
Thyssen, An
|
|
2010
|
|
9 |
p. 1011-1021
|
artikel
|
| 139 |
Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Rivaroxaban—an Oral, Direct Factor Xa Inhibitor—Are Not Affected by Aspirin
|
Kubitza, Dagmar
|
|
2006
|
|
9 |
p. 981-990
|
artikel
|
| 140 |
Sex-Related Differences in the Pharmacokinetics of Oral Ciprofloxacin
|
Overholser, Brian R.
|
|
2004
|
|
9 |
p. 1012-1022
|
artikel
|
| 141 |
Simvastatin does not have a Clinically Significant Pharmacokinetic Interaction with Fenofibrate in Humans
|
Bergman, Arthur J.
|
|
2004
|
|
9 |
p. 1054-1062
|
artikel
|
| 142 |
Single-Dose and Multiple-Dose Pharmacokinetics and Safety of Telbivudine After Oral Administration in Healthy Chinese Subjects
|
Hu, Pei
|
|
2006
|
|
9 |
p. 999-1007
|
artikel
|
| 143 |
Single-Dose and Steady-State Pharmacokinetics of Eslicarbazepine Acetate (BIA 2-093) in Healthy Elderly and Young Subjects
|
Almeida, Luis
|
|
2005
|
|
9 |
p. 1062-1066
|
artikel
|
| 144 |
Single-Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers
|
Faessel, Hélène M.
|
|
2006
|
|
9 |
p. 991-998
|
artikel
|
| 145 |
Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Does Not Affect the Pharmacokinetics of Ethinyl Estradiol or Norethindrone in Healthy Female Subjects
|
Migoya, Elizabeth
|
|
2011
|
|
9 |
p. 1319-1325
|
artikel
|
| 146 |
Steady-State Pharmacokinetics and Dose Proportionality of Troglitazone and Its Metabolites
|
Loi, Cho-Ming
|
|
1999
|
|
9 |
p. 920-926
|
artikel
|
| 147 |
Steady-State Pharmacokinetics Following Application of a Novel Transdermal Estradiol Spray in Healthy Postmenopausal Women
|
Morton, Terri L.
|
|
2009
|
|
9 |
p. 1037-1046
|
artikel
|
| 148 |
Submitting Manuscripts to the Journal of Clinical Pharmacology
|
|
|
2005
|
|
9 |
p. 975-975
|
artikel
|
| 149 |
Synergy Between Scientific Advancement and Technological Innovation, Illustrated by a Mechanism-Based Model Characterizing Sodium—Glucose Cotransporter-2 Inhibition
|
Liping Zhang,
|
|
2010
|
|
9 |
p. 113S-120S
|
artikel
|
| 150 |
Tegaserod Coadministration Does Not Alter the Pharmacokinetics of Theophylline in Healthy Subjects
|
Zhou, Honghui
|
|
2001
|
|
9 |
p. 987-993
|
artikel
|
| 151 |
20th-Century Advances in Clinical Pharmacology
|
Keefe, Deborah L.
|
|
2000
|
|
9 |
p. 907-907
|
artikel
|
| 152 |
20th-Century Advances in Drug Therapy in Oncology—Part I
|
Dutcher, Janice P.
|
|
2000
|
|
9 |
p. 1007-1024
|
artikel
|
| 153 |
The Bioequivalence of Telithromycin Administered Orally as Crushed Tablets Versus Tablets Swallowed Whole
|
Lippert, Christina
|
|
2005
|
|
9 |
p. 1025-1031
|
artikel
|
| 154 |
The Birth of Ocular Pharmacology in the 20th Century
|
Williams, Patricia B.
|
|
2000
|
|
9 |
p. 990-1006
|
artikel
|
| 155 |
The Clinical Pharmacokinetics of Phosphodiesterase-5 Inhibitors for Erectile Dysfunction
|
Gupta, Manish
|
|
2005
|
|
9 |
p. 987-1003
|
artikel
|
| 156 |
The Effect of Acid Reduction With a Proton Pump Inhibitor on the Pharmacokinetics of Lopinavir or Ritonavir in HIV-Infected Patients on Lopinavir/Ritonavir-Based Therapy
|
Overton, Edgar T.
|
|
2010
|
|
9 |
p. 1050-1055
|
artikel
|
| 157 |
The Effect of Age and Gender on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase
|
Khosravan, Reza
|
|
2008
|
|
9 |
p. 1014-1024
|
artikel
|
| 158 |
The Effects of N-Acetylcysteine and Deferoxamine on Plasma Cytokine and Oxidative Damage Parameters in Critically Ill Patients With Prolonged Hypotension: A Randomized Controlled Trial
|
Fraga, Cassiana Mazon
|
|
2012
|
|
9 |
p. 1365-1372
|
artikel
|
| 159 |
The Emerging Scientific Discipline of Pharmacometrics
|
Pfister, Marc
|
|
2010
|
|
9 |
p. 6S-6S
|
artikel
|
| 160 |
The Influences of Renal Function and Maturation on Vancomycin Elimination in Newborns and Infants
|
Capparelli, Edmund V.
|
|
2001
|
|
9 |
p. 927-934
|
artikel
|
| 161 |
The Need for Modeling and Simulation to Design Clinical Investigations in Children
|
Jadhav, Pravin R.
|
|
2010
|
|
9 |
p. 121S-129S
|
artikel
|
| 162 |
The Pharmacokinetics and Pharmacodynamics of Irbesartan in Heart Failure
|
Kostis, John B.
|
|
2001
|
|
9 |
p. 935-942
|
artikel
|
| 163 |
The Plasma Concentration and LDL-C Relationship in Patients Receiving Ezetimibe
|
Ezzet, F.
|
|
2001
|
|
9 |
p. 943-949
|
artikel
|
| 164 |
Thirty-Eighth Annual Meeting American College of Clinical Pharmacology September 13-15, 2009 San Antonio, Texas
|
|
|
2009
|
|
9 |
p. 1091-1130
|
artikel
|
| 165 |
Thirty-Seventh Annual Meeting American College of Clinical Pharmacology September 14-16, 2008 Philadelphia, Pennsylvania
|
|
|
2008
|
|
9 |
p. 1099-1135
|
artikel
|
| 166 |
Tigecycline Pharmacokinetics in Subjects With Various Degrees of Renal Function
|
Korth-Bradley, Joan M.
|
|
2012
|
|
9 |
p. 1379-1387
|
artikel
|
| 167 |
Valdecoxib, a COX-2-Specific Inhibitor, Does not Affect Cardiac Repolarization
|
Sarapa, Nenad
|
|
2003
|
|
9 |
p. 974-982
|
artikel
|
| 168 |
Visualization Concepts to Enhance Quantitative Decision Making in Drug Development
|
Dykstra, Kevin
|
|
2010
|
|
9 |
p. 130S-139S
|
artikel
|
| 169 |
Which Studies of Therapy Merit Credence? Vitamin E and Estrogen Therapy as Cautionary Examples
|
Spector, Reynold
|
|
2002
|
|
9 |
p. 955-962
|
artikel
|
Tijdschrift beschrijving